WVE
Wave Life Sciences Ltd.
Wave Life Sciences Ltd. (WVE) has 7 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Mar 30, 2026.
The most active filer is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. with 3 filings. Insiders have net bought $53.9M over the trailing 6 months. The largest single insider purchase in this window was $32.3M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on Mar 26, 2026.
- Industry:Biotechnology
- CEO:Paul Bolno
- Employees:317
- HQ:Singapore, CE, SG
- IPO:2015-11-11
Insider Buying
$54.6M
reported purchases (SEC code P)
Insider Selling
$758K
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 5,305,782 | $32.3M | Mar 30 | SEC ↗ | |
| Director, 10% Owner | Purchase | 2,495,623 | $16.0M | Mar 30 | SEC ↗ | |
| Director, 10% Owner | Purchase | 971,091 | $6.3M | Mar 30 | SEC ↗ | |
| See Remarks | Sale | 33,194 | $500K | Feb 27 | SEC ↗ | |
Vargeese ChandraFirst filing | See Remarks | Sale | 3,228 | $43K | Feb 11 | SEC ↗ |
Francis ChrisFirst filing | See Remarks | Sale | 1,883 | $25K | Feb 11 | SEC ↗ |
Moran KyleFirst filing | Chief Financial Officer | Sale | 3,588 | $48K | Feb 11 | SEC ↗ |
BOLNO PAULFirst filing | President and CEO | Sale | 10,480 | $141K | Feb 11 | SEC ↗ |
Related companies
Wave Life Sciences Ltd. is in the Healthcare sector.